Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: a multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group.
Bamias A, Aravantinos G, Deliveliotis C, Bafaloukos D, Kalofonos C, Xiros N, Zervas A, Mitropoulos D, Samantas E, Pectasides D, Papakostas P, Gika D, Kourousis C, Koutras A, Papadimitriou C, Bamias C, Kosmidis P, Dimopoulos MA; Hellenic Cooperative Oncology Group.
Bamias A, et al. Among authors: mitropoulos d.
J Clin Oncol. 2004 Jan 15;22(2):220-8. doi: 10.1200/JCO.2004.02.152. Epub 2003 Dec 9.
J Clin Oncol. 2004.
PMID: 14665607
Clinical Trial.